☰

Aaron Muth - Publications

Affiliations: 
2016 Pharmacy St John's University 
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kanabar D, Muth A. Exploring gankyrin's role in cancer development and its potential as a therapeutic target. Future Medicinal Chemistry. PMID 32892644 DOI: 10.4155/Fmc-2020-0200  0.324
2020 Kanabar D, Farrales P, Kabir A, Juang D, Gnanmony M, Almasri J, Torrents N, Shukla S, Gupta V, Dukhande VV, D'Souza A, Muth A. Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30: 127372. PMID 32738965 DOI: 10.1016/J.Bmcl.2020.127372  0.414
2020 Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, Gupta V. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. PMID 32693132 DOI: 10.1016/J.Ijbiomac.2020.07.124  0.3
2020 Wang X, Parvathaneni V, Shukla SK, Kanabar DD, Muth A, Gupta V. Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol-Applications in Non-small Cell Lung Cancer Treatment. Aaps Pharmscitech. 21: 183. PMID 32632576 DOI: 10.1208/S12249-020-01724-X  0.332
2020 Parvathaneni V, Kulkarni NS, Chauhan G, Shukla SK, Elbatanony R, Patel B, Kunda NK, Muth A, Gupta V. Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC). Materials Science & Engineering. C, Materials For Biological Applications. 115: 111139. PMID 32600728 DOI: 10.1016/J.Msec.2020.111139  0.351
2020 Shukla SK, Kulkarni NS, Farrales P, Kanabar DD, Parvathaneni V, Kunda NK, Muth A, Gupta V. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer. Pharmaceutical Research. 37: 67. PMID 32166411 DOI: 10.1007/S11095-020-02790-3  0.313
2020 Parvathaneni V, Kulkarni NS, Shukla SK, Farrales PT, Kunda NK, Muth A, Gupta V. Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment. Pharmaceutics. 12. PMID 32121070 DOI: 10.3390/Pharmaceutics12030206  0.368
2020 Shukla SK, Chan A, Parvathaneni V, Kanabar DD, Patel K, Ayehunie S, Muth A, Gupta V. Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex Journal of Molecular Liquids. 318: 113936. DOI: 10.1016/J.Molliq.2020.113936  0.33
2019 Kanabar D, Farrales P, Gnanamony M, Almasri J, Abo-Ali EM, Otmankel Y, Shah H, Nguyen D, El Menyewi M, Dukhande VV, D'Souza A, Muth A. Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 126889. PMID 31902711 DOI: 10.1016/J.Bmcl.2019.126889  0.411
2019 Shukla SK, Kulkarni NS, Chan A, Parvathaneni V, Farrales P, Muth A, Gupta V. Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer. Pharmaceutics. 11. PMID 31661947 DOI: 10.3390/Pharmaceutics11110559  0.333
2019 Kulkarni NS, Parvathaneni V, Shukla SK, Barasa L, Perron JC, Yoganathan S, Muth A, Gupta V. Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 30946965 DOI: 10.1016/J.Ejps.2019.03.026  0.355
2019 Farrales P, Muth A. Abstract 23: Small molecule targeting of gankyrin reduces cell migration and proliferation in certain cancers Cancer Research. 79: 23-23. DOI: 10.1158/1538-7445.Am2019-23  0.442
2019 Kabir A, Muth A. Abstract 1311: Inhibition of gankyrin-tumor suppressor protein interactions due to small molecule induced conformational change Cancer Research. 79: 1311-1311. DOI: 10.1158/1538-7445.Am2019-1311  0.348
2019 Kulkarni NS, Guererro Y, Gupta N, Muth A, Gupta V. Exploring potential of quantum dots as dual modality for cancer therapy and diagnosis Journal of Drug Delivery Science and Technology. 49: 352-364. DOI: 10.1016/J.Jddst.2018.12.010  0.33
2018 Yuzhalin AE, Gordon-Weeks AN, Tognoli ML, Jones K, Markelc B, Konietzny R, Fischer R, Muth A, O'Neill E, Thompson PR, Venables PJ, Kessler BM, Lim SY, Muschel RJ. Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix. Nature Communications. 9: 4783. PMID 30429478 DOI: 10.1038/S41467-018-07306-7  0.491
2018 Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. 122: 338-347. PMID 30401652 DOI: 10.1016/J.Ijbiomac.2018.10.181  0.316
2018 DeVore SB, Young CH, Li G, Sundararajan A, Ramaraj T, Mudge J, Schilkey F, Muth A, Thompson PR, Cherrington BD. Histone citrullination represses miRNA expression resulting in increased oncogene mRNAs in somatolactotrope cells. Molecular and Cellular Biology. PMID 29987187 DOI: 10.1128/Mcb.00084-18  0.491
2018 Ledet MM, Anderson R, Harman R, Muth A, Thompson PR, Coonrod SA, Van de Walle GR. BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway. Bmc Cancer. 18: 412. PMID 29649984 DOI: 10.1186/S12885-018-4323-8  0.508
2018 Nemmara VJ, Subramanian V, Muth A, Mondal S, Salinger AJ, Maurais AJ, Tilvawala R, Weerapana E, Thompson PR. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs). Acs Chemical Biology. PMID 29341591 DOI: 10.1021/Acschembio.7B00957  0.512
2017 Young CH, Rothfuss HM, Gard PF, Muth A, Thompson PR, Ashley RL, Cherrington BD. Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells. Reproduction (Cambridge, England). 153: 1-10. PMID 29565015 DOI: 10.1530/Rep-16-0494  0.523
2017 Qin H, Liu X, Li F, Miao L, Li T, Xu B, An X, Muth A, Thompson PR, Coonrod SA, Zhang X. PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Letters. PMID 28844713 DOI: 10.1016/J.Canlet.2017.08.019  0.535
2017 Sun B, Dwivedi N, Bechtel TJ, Paulsen JL, Muth A, Bawadekar M, Li G, Thompson PR, Shelef MA, Schiffer CA, Weerapana E, Ho IC. Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα. Science Immunology. 2. PMID 28783661 DOI: 10.1126/Sciimmunol.Aal3062  0.462
2017 Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, Von Bernuth H, Zychlinsky A. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 6. PMID 28574339 DOI: 10.7554/Elife.24437  0.475
2017 Muth A, Subramanian V, Beaumont E, Nagar M, Kerry P, McEwan P, Srinath H, Clancy KW, Parelkar SS, Thompson PR. Development of a selective inhibitor of Protein Arginine Deiminase 2. Journal of Medicinal Chemistry. PMID 28328217 DOI: 10.1021/Acs.Jmedchem.7B00274  0.495
2017 Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, Bernuth Hv, Zychlinsky A. Author response: Diverse stimuli engage different neutrophil extracellular trap pathways Elife. DOI: 10.7554/Elife.24437.032  0.42
2016 Zhang X, Liu X, Zhang M, Li T, Muth A, Thompson PR, Coonrod SA, Zhang X. Peptidylarginine deiminase 1-catalyzed histone citrullination is essential for early embryo development. Scientific Reports. 6: 38727. PMID 27929094 DOI: 10.1038/Srep38727  0.503
2016 Khan SA, Edwards BS, Muth A, Thompson PR, Cherrington BD, Navratil AM. GnRH stimulates peptidylarginine deiminase catalyzed histone citrullination in gonadotrope cells. Molecular Endocrinology (Baltimore, Md.). me20161085. PMID 27603413 DOI: 10.1210/Me.2016-1085  0.522
2016 Crowley VM, Khandelwal A, Mishra S, Stothert AR, Huard DJ, Zhao J, Muth A, Duerfeldt AS, Kizziah JL, Lieberman RL, Dickey CA, Blagg BS. Development of Glucose Regulated Protein 94-Selective Inhibitors based on the BnIm and Radamide Scaffold. Journal of Medicinal Chemistry. PMID 27003516 DOI: 10.1021/Acs.Jmedchem.6B00085  0.368
2016 Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B, Thompson PR, Fillipakopoulos P, Knapp S, Venables PJ, La Thangue NB. Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Science Advances. 2: e1501257. PMID 26989780 DOI: 10.1126/Sciadv.1501257  0.527
2016 Li G, Hayward IN, Jenkins BR, Rothfuss HM, Young CH, Nevalainen MT, Muth A, Thompson PR, Navratil AM, Cherrington BD. Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland. Plos One. 11: e0147503. PMID 26799659 DOI: 10.1371/Journal.Pone.0147503  0.53
2015 Muth A, Pandey V, Han X, Altomare D, Phanstiel O. Abstract A108: Targeting sphingolipid metabolism and metastasis with motuporamine derivatives Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A108  0.389
2014 Muth A, Crowley V, Khandelwal A, Mishra S, Zhao J, Hall J, Blagg BS. Development of radamide analogs as Grp94 inhibitors. Bioorganic & Medicinal Chemistry. 22: 4083-98. PMID 25027801 DOI: 10.1016/J.Bmc.2014.05.075  0.368
2014 Muth A, Pandey V, Kaur N, Wason M, Baker C, Han X, Johnson TR, Altomare DA, Phanstiel O. Synthesis and biological evaluation of antimetastatic agents predicated upon dihydromotuporamine C and its carbocyclic derivatives. Journal of Medicinal Chemistry. 57: 4023-34. PMID 24784222 DOI: 10.1021/Jm401906V  0.306
2014 Muth A, Madan M, Archer JJ, Ocampo N, Rodriguez L, Phanstiel O. Polyamine transport inhibitors: design, synthesis, and combination therapies with difluoromethylornithine. Journal of Medicinal Chemistry. 57: 348-63. PMID 24405276 DOI: 10.1021/Jm401174A  0.357
2013 Muth A, Kamel J, Kaur N, Shicora AC, Ayene IS, Gilmour SK, Phanstiel O. Development of polyamine transport ligands with improved metabolic stability and selectivity against specific human cancers. Journal of Medicinal Chemistry. 56: 5819-28. PMID 23841465 DOI: 10.1021/Jm400496A  0.363
2013 Kurihara S, Sakai Y, Suzuki H, Muth A, Phanstiel O, Rather PN. Putrescine importer PlaP contributes to swarming motility and urothelial cell invasion in Proteus mirabilis. The Journal of Biological Chemistry. 288: 15668-76. PMID 23572531 DOI: 10.1074/Jbc.M113.454090  0.311
Show low-probability matches.